Fw: Ref.: (LML) Report to the HRC - the right to health

 

Leprosy Mailing List – May 31,  2022

 

Ref.:  (LML) Report to the HRC - the right to health

From:  Alice Cruz, Quito, Ecuador

 

 

Dear colleagues and friends,

 

I am happy to share my report about the right to the highest attainable standard of physical and mental health in English, French and Spanish. I wish to thank everyone who has contributed to it. 

 

Kind regards,

Alice

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/2d96d106-de19-4c53-a91b-d0b48b2c5ce0n%40googlegroups.com.

Fw: Ref.: (LML) Update on ILC 2022 - Extension of last date for submission of abstracts to 15 June 2022

 

 
Leprosy Mailing List – May 31,  2022

 

Ref.:  (LML) Update on ILC 2022 - Extension of last date for submission of abstracts to 15 June 2022

From:  P. Narasimha Rao, Hyderabad, India

 

Dear Pieter,

 

I am happy to post an update on ILC 2022. 

 

The preparations for the ILC 2022 are going well. The response to abstract submission is good. However, we received a number of requests for extension of the last date for abstract submission. Hence the Organising committee has decided to extend the last date for abstract submission to 15th June 2022.  I request all to avail this opportunity to submit your abstracts, in case you have not done so already. 

 

We have received about 500  delegate registrations till now, a good number of them physical delegates. All the major stakeholders have agreed to take part in the congress and many of them as official partners.  I once again take this opportunity to invite the global leprosy community to take part in this congress.  We welcome you all to India and the congress as physical delegates.

 

For those not willing to be physical delegates, please note that there is an option to be an E-delegate,  which will provide access to almost all the sessions of the conference.  There is a separate award paper session for E-delegates where students/ trainees can take part. 

 

Please visit the congress website for all the updates. https://www.ilc-india2022.com

 

 

Best regards 

 

P. Narasimha Rao, MD, D.D, PhD

Organising Secretary, 21st International Leprosy Congress. 2022

President, Indian Association of Leprologists (IAL) 

Past President, National IADVL- 2019

Coordinator, SIG-NTD, IADVL 2021-23

 

Professor of Dermatology, 

Bhaskar medical college,

Hyderabad, India

 

Mobile-+91-9849044898

Email: dermarao@gmail.com

www.ial-leprosy.org

www.ilc-india2022.com

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/ec20eaf9-fd62-47a1-9c2b-ce87c0939d48n%40googlegroups.com.

Fw: Ref.: (LML) Hosting a LML session at ILC 2022

Leprosy Mailing List – May 25,  2022

 

Ref.:  (LML) Hosting a LML session at ILC 2022

 

From:  Joseph Kawuma, Kampala, Uganda

 

 

Dear Pieter,

 

In the first place, I would like to thank Ben Naafs for his call for suggestions for a LML session at the coming congress (LML, April 10, 2022).

 

Among others, I would like to hear the presentation of experiences with the prevention of disability, especially in low endemic settings where leprosy control is (in some places) left at the mercy of other disease programs e.g. TB/leprosy, NTD or national communicable disease programs.

 

I am concerned about the loss of skills and time for basic nerve function assessment  and where it happens, interpretation and response in favour of the patient.

 

H Joseph Kawuma

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/04f7706a-32de-41bc-bf66-670d16c1facen%40googlegroups.com.

Fw: Ref.: (LML) New Publications On Cross-Cutting Issues In NTDs. May, 2022

 

Leprosy Mailing List – May 25,  2022

 

Ref.:  (LML) New Publications On Cross-Cutting Issues In NTDs. May, 2022

From:  Roos Geutjes, Amsterdam, the Netherlands

 

 

Dear colleagues, 

Exciting news! The RehApp version 2.0 is expected to be launched on June 17, 2022. The RehApp mobile application is freely available and specifically designed for fieldworkers in low-and middle-income countries. The app aims to enhance their capacity to work with people with disabilities within the community: assess their abilities and inabilities, design rehabilitation interventions, provide care and support and refer appropriately. Once downloaded, the app can be used in any setting without internet access. Scroll down to the practical materials section to find more info about the app. 

Have you already registered for the NTD NGO Network (NNN) Conference 2022? Registration is open now! 

Enjoy reading the selection of the latest NTD publications that are listed below. We offer free full text delivery services. Feel free to contact us to receive the full-text versions if these cannot be found through the InfoNTD portal. We will also gladly support you with literature searches. 

Warm regards,
Roos Geutjes

InfoNTD Coordinator
www.InfoNTD.org
info@InfoNTD.org
 

 

 

Practical materials

 

Who's aid? Findings of a dialogue series series on the decolonisation of aid.
Erasmus - International Institute of Social Studies, Partos, Kuno. 2022.
 

Introducing Mental Health and Psychosocial Support (MHPSS) in emergencies (online course)
World Health Organization. World Health Organization. 2022.

 

WHO Policy Guidance on Integrated Antimicrobial Stewardship Activities (online course)
World Health Organization . World Health Organization. 2022.
 

Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries: a WHO practical toolkit (online course)
World Health Organization . World Health Organization. 2022.
 

Curso Básico de Hansenîase (online course)
Deutsche Lepra- und Tuberkulosehilfe. 2022.
 

An Introductory Manual to Remote Service Provision for Supporting People with Disability and Leprosy
The Leprosy Mission Myanmar, NOREC. 2022.
 

RehApp - Rehabilitation Knowledge Base for fieldworkers
Download in the Playstore
Download in the App Store

 

 

 

NTDs & COVID-19

 

Neglected Tropical Diseases (NTDs) and COVID-19 Pandemic in Africa: Special Focus on Control Strategies
Aborode AT, Fajemisin EA, Aiyenuro EA, et al. Bentham Science Publishers Ltd.. Combinatorial Chemistry &amp; High Throughput Screening. 2022.

 

Ivermectin as a possible treatment for COVID-19: a review of the 2022 protocols
Marques LLM, Beneti SC, Pinzon C, et al. FapUNIFESP (SciELO). Brazilian Journal of Biology. 2024.
 

 

 

Other new publications

 

Cohort Profile: The 100 Million Brazilian Cohort
Barreto ML, Ichihara MY, Pescarini JM, et al. Oxford University Press (OUP). International Journal of Epidemiology. 2021; 51 (2) : e27-e38.
 

Investing in Health Promotion Research Among Community Health Workers in Semi-rural Uganda Using a Partnership Approach
Gibson L, Ikhile D, Nyashanu M, et al. Springer International Publishing. Global Handbook of Health Promotion Research, Vol. 1. 2022.
 

Stigma and Self-concept of Leprosy Patients
Lufianti A, Mahanani S, Idris DNT. Scientific Foundation SPIROSKI. Open Access Macedonian Journal of Medical Sciences. 2022; 10 (G) : 300-305. 
 

Evolution of Social Wellbeing of Leprosy Affected People
Ahmad S, Katoch V. Indian Journal of Leprosy. 93.
 

Introducing Mental Health and Psychosocial Support (MHPSS) in emergencies
World Health Organization . World Health Organization. 2022.
 

Mental health stigma at primary health care centres in Lebanon: qualitative study
Abi Hana R, Arnous M, Heim E, et al. Springer Science and Business Media LLC. International Journal of Mental Health Systems. 2022.
 

Leaving no one behind: targeting mobile and migrant populations with health interventions for disease elimination—a descriptive systematic review
Adams MW, Sutherland EG, Eckert EL, et al. Springer Science and Business Media LLC. BMC Medicine. 2022.
 

The Impact of the Priority Review Voucher on Research and Development for Tropical Diseases
Aerts C, Barrenho E, Miraldo M, et al. Springer Science and Business Media LLC. Pharmaceutical Medicine. 2022.
 

Deworming for adolescent girls and women of reproductive age
United Nations Children's Fund (UNICEF) , World Food Programme , World Health Organization . 2022.
 

Impact of Three to Five Rounds of Mass Drug Administration on Schistosomiasis and Soil-Transmitted Helminths in School-Aged Children in North-Central Nigeria
Griswold E, Eigege A, Adelamo S, et al. American Society of Tropical Medicine and Hygiene. The American Journal of Tropical Medicine and Hygiene. 2022.
 

High infection rates for onchocerciasis and soil-transmitted helminthiasis in children under five not receiving preventive chemotherapy: a bottleneck to elimination
Nana-Djeunga HC, Djune-Yemeli L, Domche A, et al. Springer Science and Business Media LLC. Infectious Diseases of Poverty. 2022.
 

An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol
Krolewiecki A, Enbiale W, Gandasegui J, et al. F1000 Research Ltd. Gates Open Research. 2022.
 

Strengthening preparedness against global health threats: A paradigm shift based on One Health approaches
Dente M, Riccardo F, Declich S, et al. Elsevier BV. One Health. 2022.
 

The risk and associated control problems of Human African Trypanosomosis (HAT) in the endemic foci of Greater Equatoria Region, South Sudan
Lukou YS, Atari DO, Sube KLL, et al. Informa UK Limited. African Geographical Review. 2022.
 

Monitoring the elimination of gambiense human African trypanosomiasis in the historical focus of Batié, South–West Burkina Faso
Compaoré CFA, Kaboré J, Ilboudo H, et al. EDP Sciences. Parasite. 2022.
 

Is noma a neglected/overlooked tropical disease?
Feller L, Lemmer J, Khammissa RAG. Oxford University Press (OUP). Transactions of The Royal Society of Tropical Medicine and Hygiene. 2022.
 

WHO Global Water, Sanitation and Hygiene Annual report 2020
World Health Organization . World Health Organization. 2022.
 

Integrating gender into social marketing programmes
Aya Pastrana N, Somerville C, Suggs LS. Informa UK Limited. Journal of Marketing Management. 2022.
 

 

The CUIDA Chagas Project: towards the elimination of congenital transmission of Chagas disease in Bolivia, Brazil, Colombia, and Paraguay
Sousa ASD, Vermeij D, Parra-Henao G, et al. FapUNIFESP (SciELO). Revista da Sociedade Brasileira de Medicina Tropical. 2022.
 

Response to Chagas disease in Brazil: strategic milestones for achieving comprehensive health care
Ramos Jr AN, Souza EAD, Guimarães MCS, et al. FapUNIFESP (SciELO). Revista da Sociedade Brasileira de Medicina Tropical. 2022.
 

Study about American Trypanosomiasis and Chagas Disease: An Approach towards Sexual Transmission
Gomes C, Almeida AB, Rosa AC, et al. Book Publisher International (a part of SCIENCEDOMAIN International). Emerging Trends in Disease and Health Research Vol. 7. 2022.
 

Use of benznidazole to treat chronic Chagas disease: An updated systematic review with a meta-analysis
Crespillo-Andújar C, Comeche B, Hamer DH, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2022; 16 (5) : e0010386. 
 

Digital Health and Artificial Intelligence: Advancing Healthcare Provision in Latin America
Garcia Alonso R, Thoene U, Davila Benavides D. Institute of Electrical and Electronics Engineers (IEEE). IT Professional. 2022; 24 (2) : 62-68.
 

Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial
Laman M, Tavul L, Karl S, et al. Elsevier BV. The Lancet Infectious Diseases. 2022.
 

Transfer of parasitology research to patents worldwide
Garrido-Cardenas JA, Alcayde A, Manzano-Agugliaro F, et al. Elsevier BV. Acta Tropica. 2022.
 

Target Product Profile for a rapid test for diagnosis of mycetoma at the primary health-care level
World Health Organization. 2022.
 

Target Product Profile for the detection of a case of yaws and the detection of azithromycin resistance
World Health Organization . World Health Organization. 2022.
 

Review of 2022 WHO guidelines on the control and elimination of schistosomiasis
Lo NC, Bezerra FSM, Colley DG, et al. Elsevier BV. The Lancet Infectious Diseases. 2022.
 

Worldwide and Brazilian scientific publications on Leishmaniasis in the first 19 years of 21st century: a bibliometric study.
de Melo S, Silva A, Barbosa D, et al. Journal of infection in developing countries. 2022; 16 (4) : 675-682.
 

Indoor residual spraying for the control of visceral leishmaniasis: A systematic review
Faber C, Montenegro Quiñonez C, Horstick O, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2022; 16 (5) : e0010391. 
 

Burden and risk factors of cutaneous leishmaniasis in Ethiopia: a systematic review and meta‐analysis
Shita EY, Nibret E, Munshea A, et al. Wiley. International Journal of Dermatology. 2022.
 

Impact of intensified control on visceral leishmaniasis in a highly-endemic district of Bihar, India: an interrupted time series analysis
Kumar V, Siddiqui NA, Pollington TM, et al. Elsevier BV. Epidemics. 2022.
 

Targeting research to address societal needs: What can we learn from 30 years of targeting neglected diseases?
Coburn J, Yaqub O, Chataway J. Center for Open Science. 2022.
 

Neglected tropical diseases in Australia: a narrative review.
Kurcheid J, Gordon C, Clarke N, et al. The Medical journal of Australia. 2022.
 

Mortalidade por doenças tropicais negligenciadas no Piauí, Nordeste do Brasil: tendência temporal e padrões espaciais, 2001-2018
Brito SPDS, Ferreira AF, Lima MDS, et al. FapUNIFESP (SciELO). Epidemiologia e Serviços de Saúde. 2022.
 

Interventions for Neglected Tropical Diseases Among Children and Adolescents: A Meta-analysis
Naqvi FA, Das JK, Salam RA, et al. American Academy of Pediatrics (AAP). Pediatrics. 2022.
 

 

 

Governance & Health Systems

 

Political science and global health policy
Gómez EJ, Singh P, Shiffman J, et al. Elsevier BV. The Lancet. 2022.
 

How can engagement with political science and international relations for health be improved?
Stoeva P. Elsevier BV. The Lancet. 2022.
 

Effective post-pandemic governance must focus on shared challenges
Williamson A, Forman R, Azzopardi-Muscat N, et al. Elsevier BV. The Lancet. 2022.
 

The politics of universal health coverage
Ho CJ, Khalid H, Skead K, et al. Elsevier BV. The Lancet. 2022.
 

Framing and the formation of global health priorities
Shiffman J, Shawar YR. Elsevier BV. The Lancet. 2022.

 

 

 

News & Webinars

 

NTD NGO Network (NNN) Conference - Registration is open!
The NNN is delighted to announce that this year's NTD NGO Network (NNN) Annual Conference will take place from Tuesday 13th to Thursday 15th September 2022. 
The event will be in a Hybrid format, taking place in-person in Kathmandu, Nepal as well as some elements being streamed virtually. 
Have you registered for the conference? 

 

The 7th Global Symposium on Health Systems Research (HSR2022)
HSR2022 will explore the following sub-themes:

• The politics and policies of health systems
• Intersectoral collaboration and integrative governance on the road for health in all policies
• The changing dynamics of health provision models to promote equity and the central role of human resources for health
• The role of comprehensive primary care in promoting sustainability and the contribution of new technologies

Symposium date: Oct 31th - Nov 4th, Bogota 

 

Elimination of Leprosy: Initiatives in the Americas and Africa webinar by the Sasakawa Health Foundation
Even in the midst of the novel coronavirus pandemic, efforts are being made in many South American and African countries to address the issue of leprosy. This webinar will focus on issues in South America and Africa, and will invite Ministry of Health officials, NGO representative and representative of organization of persons affected by leprosy to share the experiences and challenges in their countries and the key issues that must not be forgotten.
Date: June 7th, 11.00 - 12.30h (UTC). 

 

WHO Rehabilitation Programme - Call for membership applications 
WHO Rehabilitation Programme is delighted to announce that the call for membership applications to become part of the World Rehabilitation Alliance (WRA) is open from 20 May 2022. They invite eligible organizations to apply for membership through our website. 
 

In Conversation with Simone Diniz | Gender violence in health institutions as a global health issue (Webinar)
The Lancet Commission on Gender and Global Health in partnership with the UNU Gender and Health Hub co-present Gender violence in health institutions as a global health issue.
Date: May 25th, 12.00 - 13.00h (UTCH)
 

World Water Week 2022 - Seeing the Unseen: The Value of Water.
Online you can join us in two stints: first 23-25 August and then 29 August to 1 September. If you prefer to come to Stockholm, we welcome you from the 28 August when the first day will be filled with on-site sessions. Between 29 August and 1 September, everything can be followed both online and on-site in Stockholm.
Date: August, 23rd - Sep, 1st
 

Pastoralist water rights and governance 
The Rural Water Supply Network (RWSN), the Coalition of European Lobbies for Eastern African Pastoralim (CELEP), Agrecol Association, Germany, IWMI, SIMAVI and partners are delighted to invite you to the 4th webinar of the RWSN Early Webinar
Date: Tuesday 7 Jun 2022, 14:30 – 16:00 CEST.

 

 

GDPR & the InfoNTD newsletter

 
New EU data protection regulations came into force on 25 May 2018. We have been reviewing our practices with regards to the GDPR, including our privacy statement and mailing list.

InfoNTD sends out monthly e-mails with an overview of recent publications on NTDs and cross-cutting issues. The purpose of this activity is to keep subscribers up to date.

InfoNTD will only process the data we have (names, email addresses) for the purpose of sending you the newsletter. We take your security seriously and will never share your contact details with anyone else.

You can update your preferences or unsubscribe from this list at any time.

 

Send us an email

 

Visit our website

 

 

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/90a63340-5307-4bed-97e5-412c346c0c11n%40googlegroups.com.

Fw: Ref.: (LML) ILC India - November 2022

 

Leprosy Mailing List – May 13,  2022

 

Ref.:  (LML) ILC India - November 2022

 

From:  Paul Saunderson, Ålesund, Norway

 

Dear Pieter,

I recently attended a meeting of the organizing committee of the ILC in Hyderabad and was pleased to see that there is very good progress, with great attention to detail.  With several deadlines coming up, I would like to encourage at much participation as possible.

The Congress website <https://www.ilc-india2022.com/#> is very clear and functional. Early-bird registration closes on May 15th.

Abstract submission via the same website closes on May 31st; there are clear guidelines for abstracts.

As most people will know by now, it will be a hybrid Congress, with both in-person and online attendees.  A new feature will be of interest to many: all sessions will be recorded and will be available to view online for about 1 month after the Congress closes, but only to registered participants.  Previously, it was difficult to attend all sessions of interest, as they overlapped, but now you can!

See you in Hyderabad!

Paul

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/cd7b91fb-b1e2-4c18-a92f-900c9cd37ce1n%40googlegroups.com.

Fw: Ref.: (LML) Infolep monthly overview of new publications on leprosy - May '22

 

 

Leprosy Mailing List – May 10,  2022

 

Ref.:  (LML) Infolep monthly overview of new publications on leprosy - May '22

 

From:  Anniek Akerboom, Amsterdam, the Netherlands

 

 

Dear colleagues, 

German Leprosy Relief Association (GLRA), one of Infolep's valued partners, launched a new Basic Course in Leprosy in Brazil. It is a free online course in Portuguese for health professionals, persons affected by leprosy and their families. The interactive modules contain short videos, making it a pleasurable learning experience. Learn more and start the course >> 

The National Leprosy Programme of Côte d'Ivoire developed a Zero Leprosy Action Plan to reach leprosy targets by 2030. The plan was developed in partnership with the National Buruli Ulcer Control Programme, the Global Partnership for Zero Leprosy (GPZL), and local, national, and international partners working towards a Côte d'Ivoire free of skin neglected tropical diseases (NTDs) including leprosy. Learn more >>

Save the date! The NTD NGO Network (NNN) is pleased to announce that this year's NNN Annual Conference will take place from Tuesday 13th to Thursday 15th September 2022. The hybrid event will take place in Kathmandu, Nepal, and some elements will be streamed virtually.

The early-bird registration for the 21st International Leprosy Congress (ILC) has been extended until 15 May. Be sure to send in abstracts by 31 May. Learn more and register >>

Enjoy reading the latest publications on leprosy and have a look at the coming events below. Also, I would be happy to assist you with literature searches on Infolep.

Warm regards,

Anniek Akerboom

Infolep Coordinator
www.leprosy-information.org
a.akerboom@infolep.org
 

 

 

Highlighted

 

Curso Básico de Hansenîase
DAHW Brasil. 2022.
 

Zero leprosy: A united effort using existing & new tools but new perspectives
van Brakel W. Wolters Kluwer. Indian Journal of Medical Research. 2022.
 

Picturing health: the burden of leprosy in eastern Indonesia
Pieter Y, Grijsen ML. Elsevier BV. The Lancet. 2022; 399 (10335) : 1588-1599. 
 

 

 

Leprosy & COVID-19

 

Impact of COVID-19 Disease on Health Care Services of Leprosy Patients Attending a Tertiary Care Centre, Telangana
Indira D, Damarla SV, Padmaja P, et al. Indian Journal of Leprosy. 2022.
 

Challenges Faced by People Affected with Leprosy During the COVID-19 Pandemic: A Questionnaire Based Study
Narang T, Mehta , Rathod S, et al. Indian Journal of Leprosy. 2022.
 

Leprosy Care in the Era of COVID - 19
Kahawita IP. Nepal Journals Online (JOL). Nepal Journal of Dermatology, Venereology &amp; Leprology. 2022; 20 (1) : 4-11.

 

 

 

New publications

Feel free to contact me to receive full-text versions if these cannot be found through the Infolep portal.

 

Community perspectives on leprosy and related stigma in northern Nigeria: a qualitative study
Dahiru T, Iliyasu Z, Mande AT, et al. Lepra. Leprosy Review. 2022; 93 (1) : 48-62. 
 

The Experiences of Leprosy Clients Attending Self-Care Groups During Community-Based Rehabilitation for Fulfilling Their Health Needs
Susanto T, Bahtiar S, Deviantony F, et al. Indian Journal of Leprosy. 2022.
 

Stigma and Self-concept of Leprosy Patients
Lufianti A, Mahanani S, Idris DNT. Scientific Foundation SPIROSKI. Open Access Macedonian Journal of Medical Sciences. 2022; 10 (G) : 300-305. 
 

The end of leprosy is not imminent, but it is on the horizon.
Saunderson P, Duck M. The Indian journal of medical research. 2022.
 

Guiding policy towards zero leprosy: Challenges for modelling & economic evaluation
Blok D, De Vlas S J. Wolters Kluwer. Indian Journal of Medical Research. 2022.
 

Clinical profile of leprosy among domestic and migrant patients diagnosed at a tertiary referral centre in North Kerala: A ten-year retrospective data analysis.
George N, Majeed A, Sasidharanpillai S, et al. Indian journal of dermatology, venereology and leprology. 2022.
 

Spatial distribution pattern of new leprosy cases under 15 years of age and their contacts in Sobral, Ceará, Brazil
Linhares MSC, Kerr LRFS, Kendall C, et al. FapUNIFESP (SciELO). Ciência &amp; Saúde Coletiva. 2022; 27 (4) : 1641-1652.
 

Processo de descoberta de conhecimento aplicados no desenvolvimento de uma plataforma de análise de dados sobre a hanseníase no município de Palmas
Perim da Cunha V. Federal University of Tocantins. 2022.
 

O papel do enfermeiro no controle da hanseníase na atenção básica
Santana JS, Silva RAN, Lima TOS, et al. Research, Society and Development. Research, Society and Development. 2022; 11 (4) : e51811427664.
 

Incapacidades físicas da hanseníase em menores de 15 anos no estado do Tocantins, Brasil, 2001 a 2020
Carvalho RA, Alencar JLG, Souza SMD, et al. Research, Society and Development. Research, Society and Development. 2022; 11 (5) : e18311527995. 
 

Mycobacterium lepromatosis as Cause of Leprosy, Colombia.
Cardona-Castro N, Escobar-Builes M, Serrano-Coll H, et al. Emerging infectious diseases. 2022; 28 (5) : 1067-1068.
 

Nutritional Status of Patients With Leprosy Attending a Tertiary Care Institute in North India.
Jindal R, Nagrani P, Chauhan P, et al. Cureus. 2022; 14 (3) : e23217.
 

Serum level of Selenium, Zinc, and Vitamin C and their relation to the clinical spectrum of leprosy.
Khalid H, Mostafa M, Attia N, et al. Journal of infection in developing countries. 2022; 16 (3) : 491-499. 
 

Reduced vitamin D receptor (VDR) and cathelicidin antimicrobial peptide (CAMP) gene expression contribute to the maintenance of inflammatory immune response in leprosy patients.
de Oliveira A, Chaves A, Cardoso M, et al. Microbes and infection. 2022.
 

Are the neglected tropical diseases under control in the tri-border region between Brazil, Argentina, and Paraguay?
Oliveira F, Arcêncio R, Arcoverde M, et al. Journal of infection in developing countries. 2022; 16 (3) : 547-556.
 

A Young Female With Borderline Lepromatous Leprosy and Tuberculous Lymphadenitis: A Rare Coinfection
Sami CA, Hassan SS, Khan AH, et al. Cureus, Inc.. Cureus. 2022.
 

Challenges related to the cases of lepromatous leprosy: a report of two cases.
Alfaragi M, Ahmed F, Osman W, et al. The Pan African medical journal. 2022.
 

Leprosy: clinical and immunopathological characteristics.
Froes L, Sotto M, Trindade M. Anais brasileiros de dermatologia. 2022.

 

Validity and reliability of the NEI VFQ-25 questionnaire in Indonesian leprosy patients
Rahayu T, Menaldi SL, Irawati Y, et al. Elsevier BV. Clinical Epidemiology and Global Health. 2022.
 

Population-wide active case finding and prevention for tuberculosis and leprosy elimination in Kiribati: the PEARL study protocol.
Coleman M, Hill J, Timeon E, et al. BMJ open. 2022; 12 (4) : e055295.
 

Accuracy of rapid point-of-care serological tests for leprosy diagnosis: a systematic review and meta-analysis.
Romero C, Castro R, Brasil P, et al. Memorias do Instituto Oswaldo Cruz. 2022.
 

Editorial: The Role of Biomarkers in the Immunopathology and Diagnosis of Immune Exacerbations in Leprosy-New Frontiers to Manage This Neglected Disease.
Antas P, Santos D. Frontiers in medicine. 2022.
 

LepVax as a Promising Specific Vaccine for Leprosy: A Narrative Review
Adnan ML. Cambridge Medicine Journal. Cambridge Medicine Journal. 2022.
 

Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan.
Andrade E, Brandão J, da Silva J, et al. Antimicrobial agents and chemotherapy. 2022.
 

Drug resistance in leprosy: an update following 70 years of chemotherapy.
Aubry A, Rosa SP, Chauffour A, et al. Infectious diseases now. 2022.
 

Innovative drug delivery systems for leprosy treatment
da Rocha NP, Barbosa EJ, Barros de Araujo GL, et al. Scientific Scholar. Indian Journal of Dermatology, Venereology and Leprology. 2022.
 

Grade 2 disability among leprosy patients: A pilot study from an endemic area of Central India
Ganguly S, Shravani B, Shukla A, et al. Medknow. Journal of Family Medicine and Primary Care. 2022; 11 (4) : 1416.
 

Disease Disruption among People Affected by Leprosy
Govindharaj P, Srinivasan S, Darlong J. Indian Journal of Leprosy. 2022.
 

Ultrasonography as a diagnostic tool for Neural Pain in Leprosy.
Spitz C, Mogami R, Pitta I, et al. PLoS neglected tropical diseases. 2022; 16 (4) : e0010393.
 

Novel Recommendations to Enhance the Quality of Life in Patients with Neuropathy in Hansen's Disease
Abirami C, Kar HK. Indian Journal of Leprosy. 2022.
 

Analysis of therapeutic effectiveness and adverse effects of long-term corticosteroids among leprosy patients with reactions: A retrospective cohort study
Siagian JN, Purwantyastuti , Instiaty , et al. SAGE Publications. SAGE Open Medicine. 2022.
 

Leprosy Reactions and Neuropathic Pain in Pure Neural Leprosy in a Reference Center in Rio de Janeiro - Brazil.
Pitta I, Hacker M, Vital R, et al. Frontiers in medicine. 2022.
 

Epidemiological and clinical characterization of paraguayan patients with leprosy and household contacts before and after treatment with multi-drug therapy
Maiz GE, Rojas LE, Pereira JG, et al. Instituto de Investigaciones en Ciencias de la Salud. Anales de la Facultad de Ciencias Médicas (Asunción). 2022; 55 (1) : 49-62. 
 

Epidemiological Determinants of Leprosy in a High Endemic District of India: A Community Based Case Control Study
Karotia D, Kishore J, Kumar A. Indian Journal of Leprosy. 2022.
 

Construction and Analysis of the Complete Genome Sequence of Leprosy Agent Mycobacterium lepromatosis
Silva FJ, Santos-Garcia D, Zheng X, et al. American Society for Microbiology. Microbiology Spectrum. 2022.
 

In the footsteps of Albert Calmette: an ecological study of TB, leprosy and potential exposure to wild-type Mycobacterium bovis.
Pépin J, Fox A, LeBlanc L, et al. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2022
 

 

 

 

Events

 

NNN Conference
13-15 Sep 2022
Kathmandu & Virtual

COR-NTD Annual Meeting 2022
4 - 5 Oct | Virtual

 

21st International Leprosy Congress
>> Early-bird registration by 15 May
>> Abstract submission by 31 May
8-11 Nov 2022
Hyderabad & Virtual

 

 

Links

 

Info Hansen - A innovative hub for knowledge sharing about Hansen's Disease
 

ALLF - Official website of the Association des Léprologues de Langue Française
 

LML - Leprosy Mailing List - a free moderated email list that allows all persons interested in leprosy to share ideas, information, experiences and questions
 

InfoNTD - Information on cross-cutting issues in Neglected Tropical Diseases (NTDs)

 

ILEP newsletter archive

GPZL newsletter archive

WHO Goodwill Ambassador's Leprosy Bulletin

Leprosy Review

Leprosy Review Repository (1928-2001)

Fontilles Revista de Leprología

Indian Journal of Leprosy

Hansenologia Internationalis

 

GDPR & the Infolep newsletter

 
New EU data protection regulations came into force on 25 May 2018. We have been reviewing our practices with regards to the GDPR, including our privacy statement and mailing list.

Infolep sends out monthly e-mails with an overview of recent publications on leprosy and related issues. The purpose of this activity is to keep subscribers up to date.

Infolep will only process the data we have (names, email addresses) for the purpose of sending you the newsletter. We take your security seriously and will never share your contact details with anyone else.

You can update your preferences or unsubscribe from this list at any time.

 

Send us an email

 

Visit our website

 

Facebook

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/0d4f4c4b-d609-4cba-b90c-4d5ea40e0b98n%40googlegroups.com.

Fw: Ref.: (LML) Support for participation of people affected by leprosy - non-colony representation

 

 
Leprosy Mailing List – May 5,  2022

 

Ref.:  (LML) Support for participation of people affected by leprosy - non-colony representation

 

From:  PK Jayashree, Bangalore, India

 

Dear Pieter,

 

Greetings from Bangalore, India!

 

This may not be the space to speak about it - however I was wondering if there is a way we can support those affected by Leprosy to participate proactively at the ILC. I was thinking of people who want to be at the event, absorb the proceedings, deliberate, take value and be engaged at a deeper level in the work. 

 

There may be many people whose participation may not be from the leprosy colonies but are people who have the experience of Leprosy and want to contribute. These may be people who can speak for leprosy, if given an opportunity. People like me, who belong on the board of more than one charity (and board memberships are pro-bono). Since we do not belong exclusively to any one organisation, but belong to the work and speak for the work, we are often overlooked or passed over. The costs of registering as an individual may seem high to most. 

 

I would love to hear from you all. The ILC should have enough people affected especially from the non-colony sector, participating. Especially those who can contribute. The ILC without enough representation of people affected living outside the colonies, would not be a balanced one, in my view. Especially since we are talking about people moving into communities and colonies becoming history, if we are to truly integrate everyone into the society.

 

Thanks and regards,

 

Jayashree

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/e1092b3c-32ce-4fd4-ad6f-aec16a2393dcn%40googlegroups.com.

Fw: Ref.: (LML) A critical appraisal of the ENLIST severity scale for erythema nodosum leprosum

 
Leprosy Mailing List – May 4,  2022

 

Ref.:  (LML) A critical appraisal of the ENLIST severity scale for erythema nodosum leprosum

From:  Ben Naafs, Munnekeburen, the Netherlands

 

Dear Pieter,

 

I just read a to-the-point paper on PLOS NTD by Bhushan Kumar, Hitaishi Mehta,Tarun Narang and Sunil Dogra: "A critical appraisal of the ENLIST severity scale for erythema nodosum leprosum". https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0010378

 

Their closing paragraph of this article suggests the following:

"We would suggest that in the next revision of this useful scale, the authors should consider adding that presence of iritis/ iridocyclitis, orchitis, ulcerated/ necrotic skin lesions, and severe neuritis (even in the absence of skin lesions), whatever may be the score, should be labelled as severe ENL. This approach is similar to the lines on which authors have decided to categorize chronic ENL under 'severe' disease (even when the symptoms and signs do not qualify for that label) being fully aware that the episode of reaction is not always 'severe' in degree–; it is the sequelae that are of importance even if they affect a minority of the patients. So, for scoring, it should not matter when an important/ vital organ is involved in 1in 10 or 1 in 1000 patients. Further, various ambiguities in the terminology for scoring should be clarified–if the scale is intended to be ultimately used by health workers, physiotherapists or general duty medical officers involved in care of leprosy affected people."

 

 

I have always had difficulties using the ENLIST scale, and continue to use clinical impressions as before. The more, because it is an intermittent severe illness superimposed on the chronic Lepromatous Leprosy that except from acute damage to the eyes and testes usually leads to minimal damage to the nerves and other organs. As a researcher, I felt some guilt because I could not compare my findings and results with some other papers. But as a clinician, I felt comfortable and could still compare with others who used their clinical impression too. A scale would be useful, but it should be easily applicable for a clinician without too much time.

 

Maybe a topic for the congress in Hyderabad?

 

Ben

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/69b25e51-dccd-4e9b-a46f-a9b06cde0ba7n%40googlegroups.com.

Fw: Ref.: (LML) 21st International Congress 2022, 8 – 11 November 2022, Hyderabad, India – Congress Brochure

 

 
Leprosy Mailing List – May 4,  2022

 

Ref.:  (LML) 21st International Congress 2022, 8 – 11 November 2022, Hyderabad, India – Congress Brochure

 

From:  Pieter Schreuder, Maastricht, the Netherlands

 

 

Dear colleagues,

 

By attached file the Congress Brochure of the coming International Leprosy Congress. With permission, I reprint the Welcome Message by P Narasimba Rao of the Organizing Committee.

The 21st International Leprosy Congress (ILC) is one of the world's most significant conferences bringing together National and International experts on a single platform to meet, exchange knowledge and discuss the latest developments in the field of leprosy. The theme of the conference is Better Knowledge, Early Diagnosis and Improved Care.

The Congress is being organized by IAL and IADVL with the support of Central Leprosy Division (CLD) NLEP, MoH&FW, Govt of India; under the auspices of International Leprosy Association (ILA). Number of international leprosy stakeholders like ILEP, LEPRA, Sasakwa Leprosy Initiative and TLMI, have already agreed to be the official partners of this congress.

The 21st ILC will be held in India from 8th to 11th November 2022 at the prestigious HITEX Exhibition and Convention Centre, Hyderabad. The Congress will be held in a Hybrid Model with both physical and web-based sessions which allows more then 110 hours of scientific sessions with ability to accommodate over 2,500 physical delegates, and unlimited virtual participation. It plans to focus on the major breakthroughs and advances in various aspects of leprosy such as diagnostics, therapy, epidemiology and their impact on clinical practice and management of leprosy.

The ILC 2022 gives world renowned leprologists, National program managers, NGOs, social scientists and leprosy workers a prestigious platform to present their latest research, share their best clinical experiences, ILC 2022 also offers young researchers a range of rewards, as well as an unparalleled level of exposure at this congress.

ILC 2022 has also initiated Abstract Mentor Program (AMP) for 21st ILC 2022 with the objective to support the needy leprosy Health-care providers & researchers, young scholars and students to improve their abstracts before submitting them, in order to increase the chance of their work being presented at the congress.

The participation, support and partnership of all leprosy institutions and organisations is essential for the success of the congress to make it a strategic meet in our fight against leprosy. Our aim is to serve a wide variety of interests, including that of People affected by leprosy, health care professionals and scholars to exchange stimulating new ideas for the elimination of leprosy.

We, the organizing committee, are making all the efforts to make this congress relevant and successful. We invite you and your organisation to take part in this congress in full measure so that together we can work for attaining the national and global goals of leprosy elimination.

We welcome you to take part in this congress.

P Narasimha Rao
On behalf of Organizing Committee
21st International Leprosy Congress 2022
21st International Leprosy Congress 2022 | 01
email:ilc2022india@gmail.com

mobile:+91-9849044898

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/6186a0d2-5c17-4754-aab7-aef304cb267fn%40googlegroups.com.